RNA sequencing data from relapsed AML patient-derived bone marrow samples further confirmed that GLI1, PTCH1, SMO, and components of the PI3K/AKT signaling cascade were upregulated in relapsed AML patients compared to AML patients achieving complete remission. Here, GLI1 is linked to acute myeloid leukemia.